SANTA CLARA, Calif.–Agilent Technologies Inc. (NYSE:A) today announced that Padraig McDonnell has assumed the role of Agilent CEO, effective immediately. His appointment is part of the company’s CEO transition plan announced Feb. 21. McDonnell is the fourth CEO in Agilent’s history and succeeds Mike McMullen, who will serve as an adviser until he retires Oct. […]

BRANFORD, Conn. — Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced upgrades to its Platinum® Analysis Software to reduce processing time and increase output and precision of Next-Generation Protein Sequencing™ (NGPS) data from the Platinum® instrument. “A core component of our Platinum Analysis Software is a database of predicted kinetic signatures that today, contains […]

MINNEAPOLIS — Bio-Techne Corporation (NASDAQ: TECH) today announced the appointment of Dr. Judith Klimovsky to serve as an independent director on the Company’s Board of Directors, April 24, 2024. Dr. Klimovsky will serve as a member of the Science and Technology Committee. Following the appointment, the board of Bio-Techne will be temporarily comprised of eleven directors, ten […]

SANTA CLARA, Calif. – Agilent Technologies, Inc. (NYSE: A) today announced Simon May has been named president of the company’s Diagnostics and Genomics Group (DGG). May, previously executive vice president and president of the Life Science Group at Bio-Rad Laboratories, will join Agilent on May 6. “We are excited to welcome Simon May to the Agilent team,” […]

MINNEAPOLIS — Bio-Techne Corporation (NASDAQ: TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities is pleased to announce a significant milestone in its commitment to providing cutting-edge solutions to its customers. Effective May 1, 2024, Bio-Techne will enter into a strategic distribution agreement with Thermo Fisher Scientific, […]

Beijing, China — Sino Biological, Inc. (“Sino Biological” or the “Company”), a biotechnology company listed on the Shenzhen stock exchange subsidiary ChiNext (SZSE: 301047), specializing in biological research reagents and related technical contract research services, has successfully concluded its acquisition of Vancouver-based Canadian biotechnology company SignalChem Biotech Inc. (“SCB” or “SignalChem”). Sino Biological has acquired 100% of SCB shares in […]

HERCULES, Calif. — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced the promotion of James J. Barry, currently Senior Vice President of Global Manufacturing, to the position of Executive Vice President and President of the Life Science Group, effective May 1, 2024. He […]

German Chancellor Olaf Scholz emphasizes significance for Germany as research location at cornerstone laying ceremony Research center to accelerate biopharmaceutical product development Part of Merck’s € 1.5 billion investment program in Darmstadt by 2025 DARMSTADT, GERMANY — Merck, a leading science and technology company, is investing more than € 300 million in a new research […]

LIMERICK, Pa .— The Jackson Laboratory (JAX), an independent, nonprofit biomedical research institution dedicated to discovering the genetic and genomic basis of diseases, has entered an exclusivity agreement with Rockland Immunochemicals, Inc. (Rockland) and antibodies-online GmbH (antibodies-online) to provide genomic engineering tools for immuno-oncology research and the development of diagnostics and therapeutics across the globe. […]

KITCHENER, ON, CANADA — Nicoya®, a pioneering life science instrument company specializing in innovative biosensor technology, is pleased to announce the appointment of TrioBio as its exclusive distributor in China. Following the recent expansion into the Indian market in February, this partnership marks another significant step forward in Nicoya’s mission to deliver cutting-edge research solutions globally. […]